SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HGR - Undervalued at 15 ( acquired novacare/will 2x reven

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10PreviousNext  
To: Sleepman who wrote (12)1/7/2000 6:41:00 PM
From: Ed Ajootian   of 14
 
Dan,

They are having growing pains. Nothing wrong with that, but the analysts despise companies that do not whisper warnings of such things in their ears prior to them finishing the quarter. If the company gives absolutely no guidance to the analysts about problems it is having, the net result is what you saw today, and everyone --- the company, the analysts, and the shareholders --- all look like a horse's ass.

This problem is particularly harsh for HGR due to the high percentage of their shares that are held by institutions. Institututions are less patient with bad news because the fund managers want to make their bonuses _this year and don't care how much it may go up in 2 -- 3 years.

Have a great weekend!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10PreviousNext